Remove Patients Remove Pharmaceutical Remove Safety
article thumbnail

Does “low dose” CBD pose a risk to liver health?

Project CBD

A recent clinical trial raises questions about the safety of widely consumed CBD capsules, gummies, edibles, oils and lotions that are omnipresent in the United States and many other countries. In all cases, the liver enzyme levels returned to normal within one or two weeks of stopping CBD.

CBD 205
article thumbnail

Australia Cannabis Q&A

Canna Law Blog

Follow strict patient verification and dispensing rules. Can businesses cultivate cannabis for pharmaceutical research? Under the Therapeutic Goods Act and respective State/Territory guidelines, advertising medicinal cannabis directly to patients can violate advertising laws. Pharmacies must: Be registered in Australia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Patient’s Guide to Medical Marijuana Edibles in Miami

LifeCannMD

Today, she maintains a discreet, effective regimen that has reduced her pharmaceutical intake by over half. Elena’s story sound like many of our Miami patients who find that medical marijuana edibles offer relief that helps them on a medical and personal level.

Edibles 52
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

article thumbnail

Virginia: New Medical Cannabis Laws Take Effect July 1

NORML

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 259
article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Pennsylvania-based Groff North America is one of the companies that is getting a green light to experiment with the plant. territories.

article thumbnail

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.